248 related articles for article (PubMed ID: 10643625)
41. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
42. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells.
Geerts A
Semin Liver Dis; 2001 Aug; 21(3):311-35. PubMed ID: 11586463
[TBL] [Abstract][Full Text] [Related]
43. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
Lebrec D; Sicot C; Benhamou JP
Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
[No Abstract] [Full Text] [Related]
44. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis.
Novo E; di Bonzo LV; Cannito S; Colombatto S; Parola M
Int J Biochem Cell Biol; 2009 Nov; 41(11):2089-93. PubMed ID: 19782946
[TBL] [Abstract][Full Text] [Related]
45. Histopathologic evaluation of liver biopsy for cirrhosis.
Ma C; Brunt EM
Adv Anat Pathol; 2012 Jul; 19(4):220-30. PubMed ID: 22692285
[TBL] [Abstract][Full Text] [Related]
46. [Physiopathology of portal hypertension in liver cirrhosis].
Cervela LA
Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
[No Abstract] [Full Text] [Related]
47. Liver fibrosis: searching for cell model answers.
Gutiérrez-Ruiz MC; Gómez-Quiroz LE
Liver Int; 2007 May; 27(4):434-9. PubMed ID: 17403182
[TBL] [Abstract][Full Text] [Related]
48. Intrahepatic portal venopathy and related disorders of the liver.
Chawla Y; Dhiman RK
Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
[TBL] [Abstract][Full Text] [Related]
49. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
García-Pagán JC; Gracia-Sancho J; Bosch J
J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
[No Abstract] [Full Text] [Related]
50. Endothelial cell dysfunction in microvasculature: relevance to disease processes.
Oda M; Han JY; Nakamura M
Clin Hemorheol Microcirc; 2000; 23(2-4):199-211. PubMed ID: 11321441
[TBL] [Abstract][Full Text] [Related]
51. Stem cells and hepatic cirrhosis.
Chen Z; Qi LZ; Zeng R; Li HY; Dai LJ
Panminerva Med; 2010 Jun; 52(2):149-65. PubMed ID: 20517197
[TBL] [Abstract][Full Text] [Related]
52. [Medical therapy of portal hypertension due to liver cirrhosis].
Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
[TBL] [Abstract][Full Text] [Related]
53. [Pathophysiology of hepatic fibrosis].
Vaĺková M
Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583
[TBL] [Abstract][Full Text] [Related]
54. Hepatic stellate cells and the reversal of fibrosis.
Kisseleva T; Brenner DA
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
[TBL] [Abstract][Full Text] [Related]
55. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?
Lim JK; Groszmann RJ
Hepatology; 2007 May; 45(5):1087-90. PubMed ID: 17464984
[No Abstract] [Full Text] [Related]
56. Intrahepatic modulation of portal pressure and its role in portal hypertension.
Wheatley AM; Zhang X
Digestion; 1998; 59(4):424-8. PubMed ID: 9693223
[No Abstract] [Full Text] [Related]
57. Cellular and molecular mechanisms in liver fibrogenesis.
Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
[TBL] [Abstract][Full Text] [Related]
58. Emerging therapies for portal hypertension in cirrhosis.
Nair H; Berzigotti A; Bosch J
Expert Opin Emerg Drugs; 2016 Jun; 21(2):167-81. PubMed ID: 27148904
[TBL] [Abstract][Full Text] [Related]
59. Acute-on-chronic liver failure: the liver and portal haemodynamics.
Mookerjee RP
Curr Opin Crit Care; 2011 Apr; 17(2):170-6. PubMed ID: 21346568
[TBL] [Abstract][Full Text] [Related]
60. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives.
Garbuzenko DV; Arefyev NO; Kazachkov EL
World J Gastroenterol; 2018 Sep; 24(33):3738-3748. PubMed ID: 30197479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
